Skip to content

Epstein-Barr Virus Antibody Titration (IgG and IgM)

Published: August 9, 2026Updated: August 16, 2026

This test measures the levels of Epstein-Barr virus (EBV) antibodies in your blood to help determine if you’ve been exposed to the virus and whether your immune response is active.

Quick summary

["Assesses past or current EBV infection and immune response timing."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
49069-8
Short code
EBV Ab Titr Ser
Synonyms
EBV Ab Titr Ser
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test detects two types of antibodies: IgG, which typically appears after initial infection and remains for life, and IgM, which indicates a recent or acute infection. The antibody levels are reported as a titer, or concentration, to show how strongly your immune system is responding.

Why Might You Need This Test?

Healthcare providers may order this test if you have symptoms like fever, fatigue, sore throat, or swollen lymph nodes that could suggest EBV infection (e.g., mononucleosis). It’s also used to monitor chronic conditions like infectious mononucleosis or to assess immune function in certain cases.

What to Expect Before the Test

No special preparation is needed. You’ll have a small needle inserted into a vein (usually in your arm) to draw blood. The process takes about 5 minutes, and you may feel a brief pinch. If you’re nervous, let your healthcare provider know.

What to Expect During the Test

After drawing blood, a bandage will cover the site. You can resume normal activities immediately. If you experience bruising or discomfort, apply gentle pressure to the area.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

High IgM levels suggest an active EBV infection, while high IgG levels indicate past infection. A rising IgG titer over time can help track immune response or chronic infection. This test helps diagnose conditions like mononucleosis, assess immune function, or guide treatment decisions in rare cases.

Short name

EBV Antibody Profile

Frequently asked questions

How long does it take to get results?
Results are typically available within 1 to 3 business days, depending on your lab. Your healthcare provider will discuss the findings with you during your follow-up visit.
What do my results mean?
Results show the concentration (titer) of IgG and IgM antibodies. A low or absent IgM titer suggests no recent infection, while a high IgM titer indicates an active infection. IgG levels alone may indicate past exposure. Always discuss your specific results with your doctor for personalized interpretation.
Can I have this test if I’m pregnant?
Yes, this test is generally safe during pregnancy. However, always inform your healthcare provider about any medical conditions or medications you’re taking before testing, including pregnancy status.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy